Search

Displaying results 4851 - 4860 of 5363 in total
  1. Drug

    Adarigiline

    go.drugbank.com/drugs/DB21418
    Experimental

    Adarigiline has a monoisotopic molecular weight of 360.08 Da.

  2. Drug

    Oxmetidine

    go.drugbank.com/drugs/DB21430
    Experimental

    Oxmetidine has a monoisotopic molecular weight of 399.14 Da.

  3. Drug

    Tisolagiline

    go.drugbank.com/drugs/DB21655
    Experimental

    Tisolagiline has a monoisotopic molecular weight of 322.13 Da.

  4. Drug

    Mosperafenib

    go.drugbank.com/drugs/DB21673
    Experimental

    Mosperafenib has a monoisotopic molecular weight of 461.1 Da.

  5. Drug

    Garadacimab

    go.drugbank.com/drugs/DB15629
    Approved

    [L53283,A273998] Garadacimab received its first approval in Australia and the UK in January 2025, and has since been approved in a number of other jurisdictions, including the EU and Japan.

  6. Drug

    Posizolid

    go.drugbank.com/drugs/DB04850
    Investigational

    In July 2002, after completion of phase I trials in December 2001, AstraZeneca announced that they were no longer pursuing the development of Posizolid, presumably due to negative trial results (though

  7. Drug

    Hu-rhEGF-rP64k/Mont

    go.drugbank.com/drugs/DB15781
    Investigational

    Hu-rhEGF-rP64k/Mont is a therapeutic vaccine composed by an antigen (recombinant human EGF (rhEGF) chemically conjugated to recombinant P64K (rP64K)) and an adjuvant (Montanide ISA51VG) being investigated

    Synonyms: Hu-rhEGF-rP64k/Mont
  8. Drug

    Tocofibrate

    go.drugbank.com/drugs/DB19752
    Experimental

    Tocofibrate has a monoisotopic molecular weight of 626.41 Da.

  9. Drug

    Nicofibrate

    go.drugbank.com/drugs/DB19916
    Experimental

    Nicofibrate has a monoisotopic molecular weight of 305.08 Da.

  10. Drug

    Dulofibrate

    go.drugbank.com/drugs/DB20032
    Experimental

    Dulofibrate has a monoisotopic molecular weight of 324.03 Da.